跳至主要内容
临床试验/NCT03310814
NCT03310814Unknown不适用

Building New Nutrigenomics Technology Interface Tools for Consumers and Health Professionals

Kwantlen Polytechnic University1 个研究点 分布在 1 个国家目标入组 57 人开始时间: 2017年3月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
57
试验地点
1
主要终点
Diet quality

研究概览

简要总结

This study compares the efficacy of a non-practitioner assisted direct-to-consumer (DTC) self-driven approach to nutrigenomics versus a personalized practitioner-led method. The secondary aims are to use this data combined with participant feedback to generate more effective nutrigenomics-based products.

详细描述

While nutrition is a widely accepted tool for the prevention of long-term health conditions, current approaches have not adequately reduced chronic disease morbidity. Nutrigenomics has great potential, however, it is complicated to implement. There is a need for products, derived from nutrigenomics, which are easily understood, accessible and utilized. The primary objective of this study is to compare the efficacy of a non-practitioner assisted direct-to-consumer (DTC) self-driven approach to nutrigenomics versus a personalized practitioner-led method. The secondary aims are to use this data combined with participant feedback to generate more effective nutrigenomics-based products.

Methods:

This 4-month study used a mixed-methods design that included: 1) a phase 1 randomized control trial that examined the effectiveness of a multi-faceted, nutrition-based gene test (components assessed included the major nutrients, food tolerances, food taste and preferences, and vitamins) in changing health behaviours; followed by 2) qualitative investigation that explored participants' experiences. The study recruited 57 healthy males and females (35-55 years) randomized as a 2:1 ratio where 38 received the intervention (gene-test results plus personalized nutrition report) and 19 were assigned to the control group (gene-test results report emailed). Both groups received follow-up emails with nutrition-related tips and reminders. The primary outcomes of interest measures included changes in diet (nutrients, healthy eating index), self-efficacy, quality of life and anthropometrics (BMI, waist:hip) measured at baseline, post-intervention (3 and 6 weeks), and the final visit. After the study has been completed, participants in the control group will also receive their personalized nutrition report.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
35 Years 至 55 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Adults, aged 35-55 years.
  • •Ability to understand sign an informed consent and to give a buccal DNA swab.
  • •Willing to improve their health.
  • •Medically stable. Subjects diagnosed with diet-related chronic disease were able to enroll in the study, provided that their condition was stabilized or well controlled for at least six months at the time of the baseline visit. Determination of stabilized medical condition was based on established clinical guidelines (e.g., Canadian Diabetes Association Clinical Guidelines and Canadian Cardiovascular Society Guidelines).

排除标准

  • •Currently on a therapeutic or restrictive diet (e.g., Atkins).
  • •Diagnosis of 2 or more chronic diseases or unstable chronic disease as deemed by accepted clinical guidelines.
  • •Clinical diagnosis of any mental health condition.
  • •Current or former malignancy for which the participant has undergone resection, radiation therapy or chemotherapy within 5 years prior to baseline.
  • •Diagnosis of any medical condition or disease, which in the opinion of the Principal Investigator (PI), may have either put the participant at risk, or influenced the results of the study or the participant's ability to participate in the study.
  • •Diagnosis of any of the following medical conditions: HIV, COPD, severe/uncontrolled asthma, cystic fibrosis, bronchiectasis, interstitial lung disease, chronic renal failure, colon or small intestine problem, liver or kidney disease.
  • •Currently enrolled or plan to be enrolled in another research study during the course of this investigation.
  • •Planned or recent (within the last 12 months) bariatric surgery.
  • •Current use of weight altering medication for the purpose of weight loss.
  • •Uncorrected hypothyroidism or hyperthyroidism in the previous 12 months.
  • •Alcohol or drug dependence during the previous 12 months.
  • •Investigators and their immediate families. Immediate family was defined as a spouse, parent, child or sibling, whether biological or legally adopted.
  • •Pregnant and/or breastfeeding.
  • •Current smoker.
  • •Any other health risk that may have impaired the study's ability to assess the impact of nutrigenomic information to improve diet and health.

研究组 & 干预措施

Personalized nutrition intervention

Experimental

Participant receives gene-test results plus personalized nutrition information from a registered dietician

干预措施: Personalized nutrition (Other)

Usual nutrigenomics intervention

Placebo Comparator

Participant receives usual nutrigenomics intervention (direct-to-consumer)

干预措施: Personalized nutrition (Other)

结局指标

主要结局

Diet quality

时间窗: 8 weeks

Healthy eating index

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Karen Davison

Principal Investigator

Kwantlen Polytechnic University

研究点 (1)

Loading locations...

相似试验